Hyalograft C autograft ()
- Region
- 🇪🇺 EU
- Company
- Anika Therapeutics S.r.l.
- Status
- Application withdrawn
- Application
- EMEA/H/C/002657
- ATC
- Not yet assigned
- Official record
- www.ema.europa.eu
Indication
Repairing defects in the cartilage of the femoral condyles and trochlea (the end of the thigh bone that forms part of the knee) caused by sudden or repetitive trauma.
Regulatory milestones
No milestones recorded in the last year.
Follow Hyalograft C autograft
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.